Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-14 Option Award | 2023-02-16 6:22 pm | N/A 2033-02-13 | IMPEL PHARMACEUTICALS INC | IMPL | Hoekman John Chief Scientific Officer | 42,500 | $0 | 42,500 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:03 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:50 pm | N/A 2021-12-22 | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 20,000 | $0 | 128,221 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:50 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 20,000 | $1.64 | 128,221 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-26 5:58 pm | N/A 2031-07-19 | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-04-27 Conversion(A) | 2021-06-07 4:57 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 73,910 | $0 | 108,496 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 6:31 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 8,523 | $8.19 | 178,153 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 6:31 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 8,523 | $0 | 178,153 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-29 6:31 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 74,180 | $0 | 178,153 (Direct) | View |
| 2021-04-27 Other | 2021-04-29 6:31 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 275 | $0 | 178,153 (Direct) | View |
Ownership | 2021-04-22 7:04 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 0 | $0 | 556,104 (Direct) | View |